Syntec Optics (OPTX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
8 Dec, 2025Executive summary
The annual meeting will be held virtually on January 20, 2026, to vote on director elections, auditor ratification, RSU grants, and amendments to the certificate of incorporation.
Shareholders of record as of November 24, 2025, are eligible to vote, with multiple voting methods available including online, phone, and mail.
Proxy materials and the annual report are accessible online, and shareholders are encouraged to vote in advance to ensure quorum.
Voting matters and shareholder proposals
Election of two directors to serve until the 2028 annual meeting.
Ratification of CBIZ, Inc. as the independent registered public accounting firm for 2025.
Approval of RSU grants under the 2023 Equity Incentive Plan.
Amendment of the Second Amended and Restated Certificate of Incorporation to modify voting requirements, director removal, and written consent provisions.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of five directors in three staggered classes; two directors are up for election.
Board committees include audit, compensation, and nominating/governance, all meeting required independence standards.
Board met four times in 2024, with all directors attending at least 75% of meetings.
Board leadership structure combines CEO and Chairman roles, periodically reviewed for effectiveness.
Board diversity matrix shows all five directors are male and white.
Latest events from Syntec Optics
- Strong H1 2025 profit growth and margin expansion driven by defense, biomedical, and communications.OPTX
Q2 202513 Feb 2026 - Gross margin rose to 29% in H1 2025 as sales and adjusted EBITDA improved year-over-year.OPTX
Q4 202413 Feb 2026 - Q1 2025 net income turned positive on 13% sales growth and improved margins.OPTX
Q1 202513 Feb 2026 - Q3 2025 revenue rose sequentially but margins fell; liquidity improved and Q4 outlook is positive.OPTX
Q3 202512 Feb 2026 - Q2 sales up 12% sequentially, product growth strong, and Q3 outlook robust.OPTX
Q2 20242 Feb 2026 - Q3 sales up 19% year-over-year, but higher costs led to a net loss; Q4 outlook is positive.OPTX
Q3 202413 Jan 2026 - Shareholders will vote on director elections, auditor ratification, and RSU grants at the virtual annual meeting.OPTX
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor ratification, RSU grants, and governance amendments.OPTX
Proxy Filing29 Nov 2025